Oncogenic Ras in tumour progression and metastasis

被引:221
作者
Giehl, K [1 ]
机构
[1] Univ Ulm, Dept Pharmacol & Toxicol, D-89069 Ulm, Germany
关键词
extracellular signal-regulated kinase (ERK); migration; phosphatidylinositol 3-kinase (PI3-K); Rho GTPases; signal transduction; transformation;
D O I
10.1515/BC.2005.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ras genes give rise to a family of related GTP-binding proteins that exhibit potent transforming potential. Mutational activation of Ras proteins promotes oncogenesis by disturbing a multitude of cellular processes, such as gene expression, cell cycle progression and cell proliferation, as well as cell survival, and cell migration. Ras signalling pathways are well known for their involvement in tumour initiation, but less is known about their contribution to invasion and metastasis. This review summarises the role and mechanisms of Ras signalling, especially the role of the Ras effector cascade Raf/MEK/ ERK, as well as the phosphatidylinositol 3-kinase/Akt pathway in Ras-mediated transformation and tumour progression. In addition, it discusses the impact of Rho GTPases on Ras-mediated transformation and metastasis.
引用
收藏
页码:193 / 205
页数:13
相关论文
共 172 条
  • [1] Blocking oncogenic Ras signaling for cancer therapy
    Adjei, AA
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (14): : 1062 - 1074
  • [2] Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma
    Aguirre, AJ
    Bardeesy, N
    Sinha, M
    Lopez, L
    Tuveson, DA
    Horner, J
    Redston, MS
    DePinho, RA
    [J]. GENES & DEVELOPMENT, 2003, 17 (24) : 3112 - 3126
  • [3] Direct integrin αvβ6-ERK binding:: implications for tumour growth
    Ahmed, N
    Niu, J
    Dorahy, DJ
    Gu, XH
    Andrews, S
    Meldrum, CJ
    Scott, RJ
    Baker, MS
    Macreadie, IG
    Agrez, MV
    [J]. ONCOGENE, 2002, 21 (09) : 1370 - 1380
  • [4] Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: A north central cancer treatment group phase II trial
    Alberts, SR
    Schroeder, M
    Erlichman, C
    Steen, PD
    Foster, NR
    Moore, DF
    Rowland, KM
    Nair, S
    Tschetter, LK
    Fitch, TR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (24) : 4944 - 4950
  • [5] MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES
    ALMOGUERA, C
    SHIBATA, D
    FORRESTER, K
    MARTIN, J
    ARNHEIM, N
    PERUCHO, M
    [J]. CELL, 1988, 53 (04) : 549 - 554
  • [6] AOKI K, 1995, CANCER RES, V55, P3810
  • [7] Aoki K, 1997, MOL CARCINOGEN, V20, P251, DOI 10.1002/(SICI)1098-2744(199710)20:2<251::AID-MC12>3.3.CO
  • [8] 2-P
  • [9] H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway
    Apolloni, A
    Prior, IA
    Lindsay, M
    Parton, RG
    Hancock, JF
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (07) : 2475 - 2487
  • [10] Ras and Rho GTPases: A family reunion
    Bar-Sagi, D
    Hall, A
    [J]. CELL, 2000, 103 (02) : 227 - 238